Stock Price Forecast

May 17, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Verastem, Inc. chart...

About the Company

We do not have any company description for Verastem, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

74

Exchange

Nasdaq

$4M

Total Revenue

74

Employees

$305M

Market Capitalization

-35.94

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VSTM News

Verastem, Inc. (VSTM)

2d ago, source: Yahoo Finance

BOSTON, May 09, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced business updates and reported ...

Buy Rating Affirmed for Verastem Amid Positive Developments and Strong Financial Position

3d ago, source:

In a report released on May 13, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Verastem (VSTM – Research Report), ...

Verastem dual approach socks LGSOC; ‘all eyes’ on phase II

2d ago, source: BioWorld

A new horizon may be opening up in low-grade serious ovarian cancer (LGSOC) with the advent of Verastem Oncology Inc.’s ...

Verastem Inc. Poised for Growth: Buy Rating Affirmed on Clinical and Regulatory Milestones

9d ago, source:

Justin Zelin, an analyst from BTIG, maintained the Buy rating on Verastem (VSTM – Research Report). The associated price target remains ...

Verastem: Q1 Earnings Snapshot

9d ago, source: WTOP News

NEEDHAM, Mass. (AP) — NEEDHAM, Mass. (AP) — Verastem Inc. (VSTM) on Thursday reported a loss of $33.9 million in its first quarter. On a per-share basis, the Needham, Massachusetts-based company said ...

Verastem, Inc. (VSTM) stock price, news, quote & history – Yahoo Finance

11d ago, source: Yahoo Finance

BOSTON, May 07, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will ...

Verastem: Q1 Earnings Snapshot

9d ago, source: Times Union

NEEDHAM, Mass. (AP) — NEEDHAM, Mass. (AP) — Verastem Inc. (VSTM) on Thursday reported a loss of $33.9 million in its first quarter. On a per-share basis, the Needham, Massachusetts-based ...

Verastem, Inc. (VSTM) stock price, news, quote & history – Yahoo Finance

10d ago, source: Yahoo Finance

BOSTON, May 09, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced business updates and reported ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...